Home › Rheumatoid Arthritis › Michigan › Ann Arbor
Rheumatoid Arthritis clinical trials in Ann Arbor, MI
5 studies for Rheumatoid Arthritis are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Ann Arbor
A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1
- Research Site, Ann Arbor
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
RecruitingObservational studyHealthy volunteers welcome
- Universtity of Michigan Health System, Ann Arbor
Dynamic Treatment Regiments for Glucocorticoid Tapering
RecruitingPhase 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
- University of Michigan, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RecruitingObservational study
- University of Michigan, Ann Arbor
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Dallas, TX7 studies
- Aurora, CO7 studies
- Boston, MA7 studies
- Altoona, PA7 studies
- Plantation, FL6 studies
- Chicago, IL6 studies
- San Diego, CA6 studies
- Mesquite, TX5 studies
- Miami, FL5 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.